Compare Eli Lilly And Co (LLY) vs Schwab US Large Cap Growth ETF (SCHG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Eli Lilly And Co vs Schwab US Large Cap Growth ETF — how do they compare? Eli Lilly And Co trades at $1,174.1 (market cap $1.02T), while Schwab US Large Cap Growth ETF trades at $34.25. The key difference: Eli Lilly And Co pays a 0.6% dividend while Schwab US Large Cap Growth ETF pays none. Which is the better fit depends on your goals.
| LLY | SCHG | |
|---|---|---|
Market Cap | $1.02T | — |
Sector | Health | Sector/Thematic |
52-Week High | $1.24K | $35.30 |
52-Week Low | $625.65 | $28.10 |
Enterprise Value | $1.06T | — |
Dividend Yield | 0.6% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Eli Lilly And Co
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →About Schwab US Large Cap Growth ETF
SCHG is an ETF that seeks to track the total return of the Dow Jones U.S. Large-Cap Growth Total Stock Market Index. The fund provides low-cost exposure to a diversified portfolio of large-capitalization U.S. companies that are classified as growth stocks based on factors such as sales, earnings, and book value growth rates. SCHG is often used by investors seeking long-term capital appreciation from market-leading companies with above-average growth potential.
Read more on SCHG →
